Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Lazard Asset Management
Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Lazard Asset Management
from 13F filings
Historical chart of Lazard Asset Management investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Lazard Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Lazard Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $16k | 980k | 0.02 |
| 2025-06-30 | $71M | 55M | 1.30 |
| 2025-03-31 | $51M | 44M | 1.15 |
| 2024-12-31 | $51M | 48M | 1.07 |
| 2024-09-30 | $69M | 59M | 1.17 |
| 2024-06-30 | $65M | 60M | 1.08 |
| 2024-03-31 | $57M | 60M | 0.94 |
| 2023-12-31 | $29M | 30M | 0.99 |
Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1
View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1